No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma
Tristan Knight(Wayne State University), Gregory A. Yanik(University of Michigan), Donna A. Wall(University of Manitoba), Kasiani C. Myers(Immune Deficiency Foundation), Seth J. Rotz(Cleveland Clinic), Michael Kent(Levine Children's Hospital), Ellen Fraint(Memorial Sloan Kettering Cancer Center), Troy C. Lund(University of Minnesota Medical Center), Muna Qayed(Emory University), Mary Eapen(Medical College of Wisconsin), Hasan Hashem(Nationwide Children's Hospital), Rasha Atshan(Medical College of Wisconsin), Neel S. Bhatt(The Ohio State University Wexner Medical Center), Christopher C. Dvorak(University of California, San Francisco), Lolie C. Yu(Louisiana State University), Kirk R. Schultz(University of British Columbia), Hemalatha G. Rangarajan(Nationwide Children's Hospital), Wing Leung(KK Women's and Children's Hospital), Akshay Sharma(St. Jude Children's Research Hospital), Kyle Hebert(Harvard University), Kanhatai Chiengthong(Thai Red Cross Society), Jeffery J. Auletta(Nationwide Children's Hospital), Julie‐An Talano(Dana-Farber Cancer Institute), Larisa Broglie(Morgan Stanley Children's Hospital), Kwang Woo Ahn(Medical College of Wisconsin), Timothy A. Driscoll(Duke Medical Center), Tim Prestidge(Starship Children's Health)
Cited by 3
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
|Journal of Clinical Oncology|2010|648
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592